We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
(-25%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-30.05%
Top 10 Holdings %
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$2.36M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.32M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.29M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$2.25M |
| 5 |
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$5.99M |
| 2 |
Commercial Metals
CMC
|
+$5.95M |
| 3 |
Benchmark Electronics
BHE
|
+$5.84M |
| 4 |
Upbound Group
UPBD
|
+$5.71M |
| 5 |
FreightCar America
RAIL
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Prestige Consumer Healthcare
PBH
$2.35B
| $1.92M | 0.28% |
35,978
-71,844
| -67% | -$3.54M |
|
|
LTRPA
77
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $1.92M | 0.28% |
86,499
+71,286
| +469% | +$1.57M |
|
78
Powell Industries
POWL
$8.46B
| $1.9M | 0.27% |
191,277
+149,523
| +358% | +$1.32M |
|
|
ISEE
79
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.9M | 0.27% |
+44,920
| New | +$2.29M |
|
|
BSTC
80
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $1.9M | 0.27% |
54,505
-30,601
| -36% | -$1.12M |
|
81
Nabors Industries
NBR
$1.23B
| $1.9M | 0.27% |
4,120
+3,512
| +578% | +$1.3M |
|
82
Advanced Energy
AEIS
$12.2B
| $1.89M | 0.27% |
54,422
-17,206
| -24% | -$503K |
|
|
RUTH
83
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $1.89M | 0.27% |
102,660
+91,732
| +839% | +$1.54M |
|
84
1-800-Flowers.com
FLWS
$245M
| $1.88M | 0.27% |
+238,728
| New | +$1.79M |
|
85
La-Z-Boy
LZB
$1.59B
| $1.88M | 0.27% |
+70,314
| New | +$1.65M |
|
|
RAX
86
DELISTED
Rackspace Hosting Inc
RAX
| $1.86M | 0.27% |
+85,974
| New | +$1.75M |
|
87
Repligen
RGEN
$7.44B
| $1.85M | 0.27% |
69,168
+42,582
| +160% | +$1.04M |
|
88
Cooper-Standard Automotive
CPS
$504M
| $1.83M | 0.26% |
25,462
-1,895
| -7% | -$134K |
|
89
AAR Corp
AIR
$5.15B
| $1.82M | 0.26% |
+78,271
| New | +$1.7M |
|
|
CNCE
90
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $1.82M | 0.26% |
133,184
+29,050
| +28% | +$418K |
|
|
FPRX
91
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.81M | 0.26% |
+44,666
| New | +$1.54M |
|
|
HAWK
92
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $1.81M | 0.26% |
+52,732
| New | +$1.92M |
|
|
EXAC
93
DELISTED
Exactech Inc
EXAC
| $1.8M | 0.26% |
88,960
-80,324
| -47% | -$1.51M |
|
94
Rigel Pharmaceuticals
RIGL
$680M
| $1.8M | 0.26% |
86,520
-38,609
| -31% | -$952K |
|
|
QEP
95
DELISTED
QEP RESOURCES, INC.
QEP
| $1.79M | 0.26% |
127,079
-145,824
| -53% | -$1.69M |
|
96
Teekay
TK
$975M
| $1.78M | 0.26% |
205,996
-64,291
| -24% | -$485K |
|
97
Perdoceo Education
PRDO
$1.9B
| $1.78M | 0.26% |
391,747
-73,320
| -16% | -$243K |
|
|
ACH
98
Accendra Health
ACH
$240M
| $1.77M | 0.26% |
+43,863
| New | +$1.63M |
|
99
Phibro Animal Health
PAHC
$1.38B
| $1.76M | 0.25% |
65,112
-105,171
| -62% | -$3.02M |
|
100
Comtech Telecommunications
CMTL
$51.8M
| $1.76M | 0.25% |
75,205
+34,605
| +85% | +$708K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2016 Portfolio in Review
As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.
- TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
- TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
- TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
- TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
- TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
- TFS Capital opened 502 new positions and closed 257 in Q1 2016.
- TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.
Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.